[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"stock-detail-ABOS":3,"homepage-market-summary":28,"stock-stats-ABOS":170},{"ticker":4,"date":5,"profile":6,"quote":14},"ABOS","2026-10-01",{"name":7,"exchange":8,"sector":9,"industry":10,"description":11,"ceo":9,"employees":12,"headquarters":13,"founded":9},"Acumen Pharmaceuticals, Inc. Common Stock","Nasdaq",null,"BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)","Acumen Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing a novel disease-modifying approach to target what it believes to be a key underlying cause of Alzheimer's disease. The company's drug candidate, ACU193, is a subclass monoclonal antibody that selectively targets amyloid-beta oligomers. The product pipelines include: ALTITUDE-AD; and INTERCEPT-AD.","61","Newton, MA",{"close":15,"open":16,"high":17,"low":15,"prev_close":16,"change":18,"percent_change":19,"volume":20,"transactions":21,"vwap":22,"high_52w":23,"low_52w":24,"avg_volume_52w":25,"range_52w_percent":26,"record_count":27},2.07,2.22,2.29,-0.15,-6.76,832145.75016,5781,2.1587,26.98,0.85500002,407735.22975810006,4.7,1319,{"status":29,"indices":30,"watchlist":72,"sectors":95,"benchmarks":150},"success",[31,39,46,53,59,66],{"symbol":32,"name":33,"price":34,"change":35,"pct_change":36,"is_up":37,"sparkline":38,"date":5},"SPX","S&P 500",7666.45,14.91,0.19,true,"0.0,3.1 2.3,5.0 4.6,8.0 6.9,10.4 9.3,13.4 11.6,9.1 13.9,11.5 16.2,13.8 18.5,16.0 20.8,10.3 23.2,9.5 25.5,2.0 27.8,2.0 30.1,5.9 32.4,6.0 34.7,3.4 37.1,7.3 39.4,8.2 41.7,9.4 44.0,8.5",{"symbol":40,"name":41,"price":42,"change":43,"pct_change":44,"is_up":37,"sparkline":45,"date":5},"NDX","NASDAQ 100",30501.56,93.06,0.31,"0.0,11.8 2.3,11.3 4.6,11.6 6.9,12.2 9.3,14.7 11.6,12.6 13.9,14.5 16.2,16.0 18.5,15.9 20.8,12.0 23.2,10.5 25.5,4.0 27.8,2.0 30.1,4.0 32.4,4.0 34.7,3.0 37.1,5.6 39.4,5.1 41.7,4.5 44.0,3.8",{"symbol":47,"name":48,"price":49,"change":50,"pct_change":51,"is_up":37,"sparkline":52,"date":5},"DJI","DOW JONES",50927,21,0.04,"0.0,2.0 2.3,3.4 4.6,6.5 6.9,8.6 9.3,10.2 11.6,7.6 13.9,8.4 16.2,10.0 18.5,13.2 20.8,11.6 23.2,12.1 25.5,10.2 27.8,11.2 30.1,12.9 32.4,13.8 34.7,11.4 37.1,13.1 39.4,13.8 41.7,16.0 44.0,15.9",{"symbol":54,"name":55,"price":56,"change":57,"pct_change":51,"is_up":37,"sparkline":58,"date":5},"COMP","NASDAQ Composite",26871.6,10.53,"0.0,9.3 2.3,10.2 4.6,11.1 6.9,13.0 9.3,14.9 11.6,12.1 13.9,13.7 16.2,16.0 18.5,16.0 20.8,11.1 23.2,10.0 25.5,3.4 27.8,2.0 30.1,5.4 32.4,5.4 34.7,3.9 37.1,6.7 39.4,6.9 41.7,6.2 44.0,6.1",{"symbol":60,"name":61,"price":62,"change":63,"pct_change":64,"is_up":37,"sparkline":65,"date":5},"RUT","RUSSELL 2000",2790.2,11.3,0.41,"0.0,2.6 2.3,2.0 4.6,3.0 6.9,6.1 9.3,8.4 11.6,7.5 13.9,8.8 16.2,10.4 18.5,11.3 20.8,10.2 23.2,11.2 25.5,10.1 27.8,8.8 30.1,12.9 32.4,13.1 34.7,12.8 37.1,14.4 39.4,15.1 41.7,16.0 44.0,15.1",{"symbol":67,"name":68,"price":69,"change":70,"pct_change":44,"is_up":37,"sparkline":71,"date":5},"VIX","CBOE VIX",16.39,0.05,"0.0,15.6 2.3,14.8 4.6,10.2 6.9,7.3 9.3,2.0 11.6,9.7 13.9,4.9 16.2,4.5 18.5,2.5 20.8,11.3 23.2,13.7 25.5,13.5 27.8,16.0 30.1,12.3 32.4,10.4 34.7,13.5 37.1,8.8 39.4,8.9 41.7,7.8 44.0,7.6",[73,80,88],{"symbol":74,"name":75,"price":76,"change":77,"pct_change":78,"is_up":37,"sparkline":79,"date":5},"NVDA","NVIDIA Corp",230.86,2.48,1.09,"0.0,13.9 7.3,16.0 14.7,14.9 22.0,6.5 29.3,10.1 36.7,7.5 44.0,2.0",{"symbol":81,"name":82,"price":83,"change":84,"pct_change":85,"is_up":86,"sparkline":87,"date":5},"AAPL","Apple Inc",330.32,-2.7,-0.81,false,"0.0,6.9 7.3,8.2 14.7,2.0 22.0,5.2 29.3,16.0 36.7,11.7 44.0,14.9",{"symbol":89,"name":90,"price":91,"change":92,"pct_change":93,"is_up":86,"sparkline":94,"date":5},"TSLA","Tesla Inc",354.11,-0.7,-0.2,"0.0,2.0 7.3,3.1 14.7,6.1 22.0,13.6 29.3,16.0 36.7,15.0 44.0,15.3",[96,101,106,111,116,121,126,131,135,140,145],{"name":97,"etf":98,"change":99,"price":100,"is_up":37},"Technology","XLK",1.05,197.81,{"name":102,"etf":103,"change":104,"price":105,"is_up":37},"Financials","XLF",0.11,53.46,{"name":107,"etf":108,"change":109,"price":110,"is_up":86},"Healthcare","XLV",-1.32,166.2,{"name":112,"etf":113,"change":114,"price":115,"is_up":86},"Consumer Cycl","XLY",-0.03,108.81,{"name":117,"etf":118,"change":119,"price":120,"is_up":86},"Consumer Staples","XLP",-0.33,80.33,{"name":122,"etf":123,"change":124,"price":125,"is_up":37},"Energy","XLE",1.95,62.7,{"name":127,"etf":128,"change":129,"price":130,"is_up":37},"Industrials","XLI",0.99,168.64,{"name":132,"etf":133,"change":119,"price":134,"is_up":86},"Materials","XLB",48.54,{"name":136,"etf":137,"change":138,"price":139,"is_up":86},"Real Estate","XLRE",-0.56,40.68,{"name":141,"etf":142,"change":143,"price":144,"is_up":37},"Utilities","XLU",0.61,39.68,{"name":146,"etf":147,"change":148,"price":149,"is_up":86},"Comm Services","XLC",-0.93,109.94,[151,156,160,165],{"ticker":152,"name":153,"price":154,"change":155,"is_up":37},"SPY","SPDR S&P 500 ETF",763.99,0.18,{"ticker":157,"name":158,"price":159,"change":44,"is_up":37},"QQQ","Invesco QQQ Trust",742.03,{"ticker":161,"name":162,"price":163,"change":164,"is_up":37},"DIA","SPDR Dow Jones ETF",508.68,0.03,{"ticker":166,"name":167,"price":168,"change":169,"is_up":37},"IWM","iShares Russell 2000",279.06,0.42,{"ticker":4,"company_name":7,"current_price":15,"data_notice":171,"valuation":172,"dates":176,"share_statistics":179,"valuation_ratios":182,"enterprise_valuation":183,"financial_position":188,"financial_efficiency":193,"taxes":198,"price_statistics":199,"income_statement":206,"balance_sheet":212,"cash_flow":221,"margins":226,"dividends":227,"analyst_forecast":230,"fair_value":232,"splits":234},"Dividend history, analyst price targets, ownership breakdown, short interest, stock splits, beta, WACC and Altman\u002FPiotroski scores are not available from any data source Bullzeno currently integrates, so those fields are omitted (null) rather than estimated.",{"market_cap":173,"enterprise_value":174,"summary":175},161990718.4,127118718.4,"ABOS has a market cap of $161,990,718.40. Enterprise value is $127,118,718.40.",{"latest_fiscal_period_end":177,"earnings_date":9,"ex_dividend_date":9,"summary":178},"2026-03-31","Most recent reported fiscal period end: 2026-03-31.",{"shares_outstanding":180,"owned_by_insiders":9,"owned_by_institutions":9,"summary":181},72317285,"ABOS has 72,317,285 shares outstanding.",{"pe_ratio":9,"ps_ratio":9,"pb_ratio":9,"pfcf_ratio":9,"pocf_ratio":9},{"ev_earnings":184,"ev_sales":9,"ev_ebitda":185,"ev_ebit":186,"ev_fcf":187},-6.13,-6.33,-6.46,-5.27,{"current_ratio":189,"debt_equity":190,"debt_ebitda":191,"debt_fcf":92,"summary":192},0.46,-0.52,-0.84,"The company has a current ratio of 0.46.",{"roe":194,"roa":195,"revenue_per_employee":9,"profit_per_employee":196,"employee_count":197,"asset_turnover":9},63.24,-155.18,-339951,61,{"income_tax":9},{"beta_5y":9,"price_change_52w":200,"ma_50":201,"ma_200":202,"rsi_14":203,"avg_volume_20d":204,"summary":205},18.29,2.61,2.51,20.89,549007,"The stock price has changed by +18.29% in the last 52 weeks.",{"revenue":9,"gross_profit":9,"operating_income":207,"pretax_income":208,"net_income":208,"ebitda":209,"ebit":210,"eps":119,"summary":211},-21149000,-20737000,-20082000,-19668000,"Income statement data is not available for this symbol.",{"cash_and_equiv":213,"total_debt":214,"net_cash":215,"net_cash_per_share":216,"equity_book_value":217,"book_value_per_share":218,"working_capital":219,"summary":220},51796000,16924000,34872000,0.48,-32790100,-0.45,-15919600,"The company reported $51,796,000.00 in cash and $16,924,000.00 in debt.",{"operating_cash_flow":222,"capital_expenditures":223,"depreciation_amortization":9,"net_borrowing":9,"free_cash_flow":224,"fcf_per_share":119,"summary":225},-16902000,0,-24128000,"Free cash flow was $-24,128,000.00.",{"gross_margin":9,"operating_margin":9,"pretax_margin":9,"profit_margin":9,"ebitda_margin":9,"fcf_margin":9},{"dividend_per_share":9,"dividend_yield":9,"earnings_yield":9,"fcf_yield":228,"summary":229},-14.89,"ABOS has no recorded dividend payments.",{"price_target":9,"price_target_diff":9,"consensus":9,"analyst_count":9,"summary":231},"Analyst price targets and consensus ratings are not available.",{"lynch_fair_value":9,"lynch_upside":9,"graham_number":9,"graham_upside":9,"summary":233},"Graham Number and Peter Lynch Fair Value are textbook valuation formulas applied to this company's real reported EPS and book value; they are estimates, not price targets or guarantees.",{"last_split_date":9,"split_type":9,"split_ratio":9,"summary":235},"Stock split history is not available for this symbol."]